How to regenerate axons to recover from spinal-cord injury

HKUST researchers cut mouse corticospinal tract axons (labeled red). A year later, they deleted the Pten gene in the experimental group (bottom) but not the control group. The Pten gene removal resulted in axon regrowth in seven months, unlike the control group (top). (credit: Kaimeng Du et al./The Journal of Neuroscience)

Researchers at the Hong Kong University of Science and Technology (HKUST) have found a way to help patients recover from chronic spinal cord injury (SCI) by stimulating the growth of axons.

Chronic SCI prevents a large number of injured axons from crossing a lesion, particularly in the corticospinal tract (CST). Patients inflicted with SCI often suffer a temporary or permanent loss of mobility and paralysis.

As reported in the July 1st issue of The Journal of Neuroscience, the researchers found that deleting the PTEN gene in mice neurons results in stimulation of growth of axons across the lesion (wound) and past it —- even when treatment was delayed up to 1 year after the original injury.

The deletion also up-regulated (increased) the activity of another gene called MTOR (the mammalian target of rapamycin), which further promoted regeneration of  the axons.

Corticospinal tract (credit: Gray’s Anatomy/Wikimedia Commons)

“As one of the long descending tracts controlling voluntary movement, the corticospinal tract (CST) plays an important role for functional recovery after spinal cord injury,” says Kai Liu, PhD, the study’s senior author and assistant professor in life sciences at HKUST.

“The regeneration of CST has been a major challenge in the field, especially after chronic injuries. Here we developed a strategy to modulate PTEN/mTOR signaling in adult corticospinal motor neurons in the post-injury paradigm.

“It not only promoted the sprouting of uninjured CST axons, but also enabled the regeneration of injured axons past the lesion in a mouse model of spinal cord injury, The results considerably extend the window of opportunity for regenerating CST axons severed in spinal cord injuries.

“It is interesting to find that chronically injured neurons retain the ability to reform tentative synaptic connections,” says Liu. “PTEN inhibition can be targeted on particular neurons, which means that we can apply the procedure specifically on the region of interest as we continue our research.”


Abstract of Pten Deletion Promotes Regrowth of Corticospinal Tract Axons 1 Year after Spinal Cord Injury

Chronic spinal cord injury (SCI) is a formidable hurdle that prevents a large number of injured axons from crossing the lesion, particularly the corticospinal tract (CST). This study shows that Pten deletion in the adult mouse cortex enhances compensatory sprouting of uninjured CST axons. Furthermore, forced upregulation of mammalian target of rapamycin (mTOR) initiated either 1 month or 1 year after injury promoted regeneration of CST axons. Our results indicate that both developmental and injury-induced mTOR downregulation in corticospinal motor neurons can be reversed in adults. Modulating neuronal mTOR activity is a potential strategy for axon regeneration after chronic SCI.

SIGNIFICANCE STATEMENT As one of the long descending tracts controlling voluntary movement, the corticospinal tract (CST) plays an important role for functional recovery after spinal cord injury. The regeneration of CST has been a major challenge in the field, especially after chronic injuries. Here we developed a strategy to modulate Pten/mammalian target of rapamycin signaling in adult corticospinal motor neurons in the postinjury paradigm. It not only promoted the sprouting of uninjured CST axons, but also enabled the regeneration of injured axons past the lesion in a mouse model of spinal cord injury, even when treatment was delayed up to 1 year after the original injury. The results considerably extend the window of opportunity for regenerating CST axons severed in spinal cord injuries.

Could this new electrical brain-zap method help you learn muscle skills faster?

Three electrical brain-stimulation methods. Vertical axis: current-flow intensity; horizontal axis: time. (adapted from Shapour Jaberzadeh et al./PLOS ONE)

Researchers headed by Shapour Jaberzadeh and his group at Monash University have discovered a new noninvasive technique that could rev up your brain to improve your physical performance — for athletes and musicians, for instance — and might also improve treatments for brain-related conditions such as stroke, depression, and chronic pain.

The two neuroelectrical treatment methods currently in use are transcranial direct current simulation (tDCS) — low intensity direct current (direct current is what a battery creates) — and transcranial alternating current simulation (tACS) — current that constantly changes and reverses polarity (alternating current, or AC, is used in houses and buildings).

Introducing transcranial pulsed current stimulation

The newest method, called transcranial pulsed current stimulation (tPCS), increases more corticospinal (muscle-movement-related) excitability, according to the researchers.

“We discovered that this new treatment produced larger excitability changes in the brain,” said Jaberzadeh. In addition, increasing the length of the pulse and decreasing the [time] interval between pulses heightened excitability even further.

The research is described in a paper published Wednesday (July 15) in the open-access journal PLOS ONE.

“When we learn a task during movement training (for example playing the piano), gradually our performance gets better. This improvement coincides with enhancement of the brain excitability. Compared to tDCS, our novel technique can play an important role in enhancement of the brain excitability, which may help recipients learn new tasks faster.”

Jaberzadeh said the technique had exciting implications for a whole host of conditions in which “enhancement of the brain excitability” has a therapeutic effect. These include training for treatment of stroke and other neurological disorders, mental disorders, and even management of pain.

“Our next step is to investigate the underlying mechanisms for the efficacy of this new technique. This will enable us to develop more effective protocols for application of tPCS in patients with different pathological conditions.”

One side effect of the treatment: the patient sees lights flashing in their eyes (retinal phosphenes) — actually a plus for trippers.

New tinnitus treatment uses TMS

Transcranial magnetic stimulation being applied for tinnitus by Sarah Theodoroff, Ph.D., assistant professor of Otolaryngology/Head and Neck Surgery at OHSU (credit: VA Portland Health Care System/OHSU)

In related neuromodulation news, transcranial magnetic stimulation (TMS) significantly improved tinnitus symptoms for more than half of study participants in recent research at the VA Portland Medical Center and Oregon Health & Science University.

“For some study participants, this was the first time in years that they experienced any relief in symptoms,” according to the the researchers.

The study was funded by the Veterans Administration and published in the journal JAMA Otolaryngology — Head & Neck Surgery.

Tinnitus affects nearly 45 million Americans. People with this condition hear a persistent sound that can range from ringing or buzzing to a hissing or white noise hum when there is no external sound source. Currently, there are no proven treatments available.

Currently, the Food and Drug Administration has only approved transcranial magnetic stimulation for treatment of depression.


Abstract of Anodal Transcranial Pulsed Current Stimulation: The Effects of Pulse Duration on Corticospinal Excitability

The aim is to investigate the effects of pulse duration (PD) on the modulatory effects of transcranial pulsed current (tPCS) on corticospinal excitability (CSE). CSE of the dominant primary motor cortex (M1) of right first dorsal interosseous muscle was assessed by motor evoked potentials, before, immediately, 10, 20 and 30 minutes after application of five experimental conditions: 1) anodal transcranial direct current stimulation (a-tDCS), 2) a-tPCS with 125 ms pulse duration (a-tPCSPD = 125), 3) a-tPCS with 250 ms pulse duration (a-tPCSPD = 250), 4) a-tPCS with 500 ms pulse duration (a-tPCSPD = 500) and 5) sham a-tPCS. The total charges were kept constant in all experimental conditions except sham condition. Post-hoc comparisons indicated that a-tPCSPD = 500 produced larger CSE compared to a-tPCSPD = 125(P<0.0001), a-tPCSPD = 250 (P = 0.009) and a-tDCS (P = 0.008). Also, there was no significant difference between a-tPCSPD = 250 and a-tDCS on CSE changes (P>0.05). All conditions except a-tPCSPD = 125 showed a significant difference to the sham group (P<0.006). All participants tolerated the applied currents. It could be concluded that a-tPCS with a PD of 500ms induces largest CSE changes, however further studies are required to identify optimal values.

Abstract of Repetitive Transcranial Magnetic Stimulation Treatment for Chronic Tinnitus: A Randomized Clinical Trial

Importance Chronic tinnitus negatively affects the quality of life for millions of people. This clinical trial assesses a potential treatment for tinnitus.

Objectives To determine if repetitive transcranial magnetic stimulation (rTMS) can reduce the perception or severity of tinnitus and to test the hypothesis that rTMS will result in a statistically significantly greater percentage of responders to treatment in an active rTMS group compared with a placebo rTMS group.

Design, Setting, and Participants A randomized, participant and clinician or observer–blinded, placebo-controlled clinical trial of rTMS involving individuals who experience chronic tinnitus. Follow-up assessments were conducted at 1, 2, 4, 13, and 26 weeks after the last treatment session. The trial was conducted between April 2011 and December 2014 at Portland Veterans Affairs Medical Center among 348 individuals with chronic tinnitus who were initially screened for participation. Of those, 92 provided informed consent and underwent more detailed assessments. Seventy individuals met criteria for inclusion and were randomized to receive active or placebo rTMS. Sixty-four participants (51 men and 13 women, with a mean [SD] age of 60.6 [8.9] years) were included in the data analyses. No participants withdrew because of adverse effects of rTMS.

Interventions Participants received 2000 pulses per session of active or placebo rTMS at a rate of 1-Hz rTMS daily on 10 consecutive workdays.

Main Outcomes and Measures The Tinnitus Functional Index (TFI) was the main study outcome. Our hypothesis was tested by comparing baseline and posttreatment TFIs for each participant and group.

Results Overall, 18 of 32 participants (56%) in the active rTMS group and 7 of 32 participants (22%) in the placebo rTMS group were responders to rTMS treatment. The difference in the percentage of responders to treatment in each group was statistically significant (χ21 = 7.94, P < .005).

Conclusions and Relevance Application of 1-Hz rTMS daily for 10 consecutive workdays resulted in a statistically significantly greater percentage of responders to treatment in the active rTMS group compared with the placebo rTMS group. Improvements in tinnitus severity experienced by responders were sustained during the 26-week follow-up period. Before this procedure can be implemented clinically, larger studies should be conducted to refine treatment protocols.

Trial Registration clinicaltrials.gov Identifier: NCT01104207

Gigapixel multicolor microscope is powerful new tool to advance drug research

Parallelized multispectral imaging. Each rainbow-colored bar is the fluorescent spectrum from a discrete point in a cell culture. The gigapixel multispectral microscope records nearly a million such spectra every second. (credit: Antony Orth et al./Optica)

A new multispectral microscope capable of processing nearly 17 billion pixels in a single image has been developed by a team of researchers from the United States and Australia — the largest such microscopic image ever created.

This level of multicolor detail is essential for studying the impact of experimental drugs on biological samples and is an important advancement over traditional microscope designs, the researchers say. The goal is to simultaneously process large amounts of data to deal with a major bottleneck in pharmaceutical research: rapid, data-rich biomedical imaging.

The microscope merges data simultaneously collected by thousands of microlenses to produce a continuous series of datasets that essentially reveal how much of multiple colors (frequencies) are present at each point in a single biological sample.

“We recognized that the microscopy part of the drug development pipeline was much slower than it could be and designed a system specifically for this task,” said Antony Orth, a researcher formerly at the Rowland Institute, Harvard University in Cambridge and now with the ARC Centre for Nanoscale BioPhotonics, RMIT University in Melbourne, Australia.

Orth and his colleagues published their results in Optica, a journal of The Optical Society.

Multispectral imaging 

Multispectral imaging is used for a variety of scientific and medical research applications. This process adds data about specific colors, or frequencies to images. Medical researchers are able to study these frequencies to learn about the composition and chemical processes that are taking place within a biological sample. This is essential for pharmaceutical research — particularly cancer research — to observe how cells and tissues respond to specific chemicals and experimental drugs.

Such research, however, is very data intensive and slow since current multispectral microscopes can only survey a single point at a time with few color channels, typically only 4 or 5. This process must then be repeated over and over to scan the entire sample.

Slices of a spectral data cube. HeLa cells are imaged at 11 wavelengths from blue to red. The bottom right panel is a composite of all wavelength channels. (credit: Antony Orth et al./Optica)

Microlenses and parallel processing for big data

To overcome these limitations, Orth and his team took inspiration from modern computing, in which massive amounts of data and calculations are simultaneous handled by multicore processors. In the case of imaging, however, the work of a single microscope lens is distributed among an entire array or microlenses, each responsible for collecting multispectral data for a very narrow portion of each sample.

To capture this data, a laser is focused onto a small spot on the sample by each microlens. The laser light causes the sample to fluoresce, emitting specific wavelengths of light that differ depending on the molecules that are present. This fluorescence is then imaged back onto the camera. This is done for thousands of microlenses at once.

This multipoint scanning greatly reduces the amount of time necessary to image a sample by simultaneously harnessing thousands of lenses.

“By recording the color spectrum of the fluorescence, we can determine how much of each fluorescing molecule is in the sample,” said Orth. “What makes our microscope particularly powerful is that it records many different colors at once, allowing researchers to highlight a large number of structures in a single experiment.”

To demonstrate their design, the researchers applied various dyes that adhere to specific molecules within a cell sample. These dyes respond to laser light by fluorescing at specific frequencies so they can be detected and localized with high precision. Each microlens then looked at a very small part of the sample, an area about 0.6 by 0.1 millimeters in size. The raw data produced by this was a series of small images roughly 1,200 by 200 pixels wide.

These individual multicolor images were then stitched together into a large mosaic image. By simultaneously imaging 13 separate colors bands, the dataset produced was nearly 17 billion pixels in size.

In scientific imaging, such multilayered files are referred to as “datacubes,” because they contain three dimensions — two spatial (the X and Y coordinates) and one dimension of color. “The dataset basically tells you how much of each color you have at any given X-Y position in the sample,” explained Orth.

This design is a significant improvement over regular, single-lens microscopes, which take a series of medium-sized pictures in a serial fashion. Since they cannot see the entire sample at once, it’s necessary to take one picture and then move the sample to capture the next. This means the sample has to remain still while the microscope is refocused or color filters are changed. Orth and his colleagues’ design eliminates much of this mechanical dead-time and is almost always imaging.

Multispectral fluorescence image of an entire cancer cell culture. A gradient wavelength filter is applied in post processing to visualize the full spectral nature of the dataset – 13 discrete wavelengths from red to blue. (credit: Antony Orth et al./Optica)

Speeding up drug discovery wtih big data

This novel approach initially presented a challenge in the data pipeline. The raw data is in the form of one megapixel images recorded at 200 frames per second — a data rate much higher than current microscopes, which required the team to capture and process a tremendous amount of data each second.

Over time, the availability and prices of fast cameras and fast hard drives have come down considerably, allowing for a much more affordable and efficient design. The current limiting factor is loading the recorded data from hard drives to active computer memory to produce an image. The researchers estimate that an active memory of about 100 gigabytes to store the raw dataset would improve the entire process even further.

The goal of this technology is to speed up drug discovery. For example, to study the impact of a new cancer drug it’s essential to determine if a specific drug kills cancer cells more often than healthy cells. This requires testing the same drug on thousands to millions of cells with varying doses and under different conditions, which is normally a very time-consuming and labor-intensive task.

The new microscope presented in this paper speeds up this process while also looking at many different colors at once. “This is important because the more colors you can see, the more insightful and efficient your experiments become,” noted Orth. “Because of this, the speed-up afforded by our microscope goes beyond just the improvement in raw data rate.”

Continuing this research, the team would like to expand to live cell imaging in which billion-pixel, time-lapse movies of cells moving and responding to various stimuli could be made, opening the door to experiments that currently aren’t possible with small-scale time-lapse movies.


Abstract of Gigapixel multispectral microscopy

Understanding the complexity of cellular biology often requires capturing and processing an enormous amount of data. In high-content drug screens, each cell is labeled with several different fluorescent markers and frequently thousands to millions of cells need to be analyzed in order to characterize biology’s intrinsic variability. In this work, we demonstrate a new microlens-based multispectral microscope designed to meet this throughput-intensive demand. We report multispectral image cubes of up to 1.26 gigapixels in the spatial domain, with up to 13 spectral samples per pixel, for a total image size of 16.4 billion spatial-spectral samples. To our knowledge, this is the largest multispectral microscopy dataset reported in the literature. Our system has highly reconfigurable spectral sampling and bandwidth settings and we have demonstrated spectral unmixing of up to 6 fluorescent channels.

Why ‘white graphene’ structures are cool

A 3-D structure of hexagonal boron nitride sheets and boron nitride nanotubes could be a tunable material to control heat in electronics, according to researchers at Rice University (credit: Shahsavari Group/Rice University)


Three-dimensional structures of boron nitride are a viable candidate as a tunable material to keep electronics cool, according to scientists at Rice University researchers Rouzbeh Shahsavari and Navid Sakhavand.

Their work appears this month in the American Chemical Society journal Applied Materials and Interfaces.

In its two-dimensional form, hexagonal boron nitride (h-BN), aka white graphene, looks just like the atom-thick form of carbon known as graphene. One difference: h-BN is a natural insulator, where perfect graphene presents no barrier to electricity (is a natural electrical conductor).

But like graphene, h-BN is a also a good conductor of heat, which can be quantified in the form of phonons. (Technically, a phonon is a “quasiparticle” in a collective excitation of atoms.)

“Typically in all electronics, it is highly desired to get heat out of the system as quickly and efficiently as possible,” he said. “One of the drawbacks in electronics, especially when you have layered materials on a substrate, is that heat moves very quickly in one direction, along a conductive plane, but not so good from layer to layer. Multiple stacked graphene layers is a good example of this.”

Heat moves ballistically across flat planes of boron nitride, too, but the Rice simulations showed that 3-D structures of h-BN planes connected by boron nitride nanotubes would be able to move phonons in all directions, whether in-plane or across planes, Shahsavari said.

Phonon flows

The researchers calculated how phonons would flow across four such structures with nanotubes of various lengths and densities. They found the junctions of pillars and planes significantly slowed down the flow of phonons from layer to layer, Shahsavari said. Both the length and density of the pillars had an effect on the heat flow: more and/or shorter pillars slowed conduction, while longer pillars presented fewer barriers and thus sped things along.

Researchers have already made graphene/carbon nanotube junctions, but Shahsavari believes such junctions for boron nitride materials could be just as promising. “Given the insulating properties of boron nitride, they can enable and complement the creation of 3-D, graphene-based nanoelectronics,” Shahsavari said.

“This type of 3-D thermal-management system can open up opportunities for thermal switches, or thermal rectifiers, where the heat flowing in one direction can be different than the reverse direction. This can be done by changing the shape of the material, or changing its mass — say one side is heavier than the other — to create a switch. The heat would always prefer to go one way, but in the reverse direction it would be slower.”


Abstract of Dimensional Crossover of Thermal Transport in Hybrid Boron Nitride Nanostructures

Although Boron Nitride nanotubes (BNNT) and hexagonal-BN (h-BN) are superb one-dimensional (1D) and 2D thermal conductors respectively, bringing this quality into 3D remain elusive. Here, we focus on Pillared Boron Nitride (PBN) as a class of 3D BN allotropes and demonstrate how the junctions, pillar length and pillar distance control phonon scattering in PBN and impart tailorable thermal conductivity in 3D. Using reverse non equilibrium molecular dynamics simulations, our results indicate that while a clear phonon scattering at the junctions accounts for the lower thermal conductivity of PBN compared to its parent BNNT and h-BN allotropes, it acts as an effective design tool and provides 3D thermo-mutable features that are absent in the parent structures. Propelled by the junction spacing, while one geometrical parameter, e.g., pillar length, controls the thermal transport along the out-of-plane direction of PBN, the other parameter, e.g., pillar distance, dictates the gross cross-sectional area, which is key for design of 3D thermal management systems. Furthermore, the junctions have a more pronounced effect in creating a Kapitza effect in the out-of-plane direction, due to the change in dimensionality of the phonon transport. This work is the first report on thermo-mutable properties of hybrid BN allotropes and can potentially impact thermal management of other hybrid 3D BN architectures.

Miniature brain organoids made from patient skin cells reveal insights into autism

A human brain organoid showing complex internal organization, with immature proliferating cells (red) and a surrounding layer of maturing neurons (green) (credit: Jessica Mariani)

Taking a radical research approach to understanding autism, Yale School of Medicine researchers converted skin cells from autism patients into stem cells and then grew them into tiny brains in a dish — revealing unexpected mechanisms of the disease.

The study was published in an open-access paper today (July 16) in the journal Cell.

Most autism research has taken the approach of combing through patient genomes for mutations that may underlie the disorder and then using animal or cell-based models to study the genes and their possible roles in brain development. That has left more than 80% of autism cases with no clear genetic cause.

“Instead of starting from genetics, we’ve started with the biology of the disorder itself to try to get a window into the genome,” says senior author Flora Vaccarino the Harris Professor of Child Psychiatry and Professor or Neurobiology at Yale.

The clinical characteristics of autism are complex and wide-ranging, making the prospect of finding common underlying factors slim. So the researchers focused on the approximately one-fifth of autism patients that share a distinctive feature correlated with disease severity — an enlarged brain.

Unexpected neuron-type imbalance

The “brain organoids” that resulted are just a few millimeters about a fifth of a millimeter in diameter but mimic the basics of early human brain development, roughly corresponding to the first few months of gestation. When the researchers analyzed the patient organoids, they uncovered altered expression networks for genes controlling neuronal development.

The patient organoids showed an unexpected overproduction of inhibitory neurons that quiet down neural activity, while those that excite the partners they’re wired to were unaffected, leading to an imbalance in neuron type. Remarkably, by suppressing the expression of a single gene whose expression was abnormally increased in patient organoids, the authors were able to correct this bias, suggesting that it may be possible to intervene clinically to restore neuronal balance.

The authors are now using their data to home in on the difficult-to-find mutations or epigenetic changes responsible for the gene expression alterations and neuronal imbalance observed in the study. Efforts to extend their growth to later embryonic stages are also under way by a number of groups and will allow even further insights into the disease mechanisms.

“This study speaks to the importance of using human cells and using them in an assay that could bring a better understanding of the pathophysiology of autism and with that, possibly better treatments,” according to Vaccarino.

The success of the approach also suggests that similar methods might be used to gain important insights into other human developmental diseases that have until now been difficult to crack open.


Abstract of FOXG1-Dependent Dysregulation of GABA/Glutamate Neuron Differentiation in Autism Spectrum Disorders

Autism spectrum disorder(ASD) is a disorder of brain development. Most cases lack a clear etiology or genetic basis, and the difficulty of re-enacting human brain development has precluded understanding of ASD pathophysiology. Here we use three-dimensional neural cultures (organoids) derived from induced pluripotent stem cells (iPSCs) to investigate neurodevelopmental alterations in individuals with severe idiopathic ASD. While no known underlying genomic mutation could be identified, transcriptome and gene network analyses revealed upregulation of genes involved in cell proliferation, neuronal differentiation, and synaptic assembly. ASD-derived organoids exhibit an accelerated cell cycle and overproduction of GABAergic inhibitory neurons. Using RNA interference, we show that overexpression of the transcription factor FOXG1 is responsible for the overproduction of GABAergic neurons. Altered expression of gene network modules and FOXG1 are positively correlated with symptom severity. Our data suggest that a shift toward GABAergic neuron fate caused by FOXG1 is a developmental precursor of ASD.

Scientists ‘watch’ rats exploring their memories

Each of the five panels shows a memory snapshot created by hundreds of place cells while the rat was physically stationary at the top of the 1.8 m track (black). The time difference between the first and last snapshot is a mere one-fifth of a second; the positions represented by the neurons are shown in bright colors. (credit: Reprinted with permission from Pfeiffer and Foster, Science, 349:180)(2015)

How do you visualize your memory? As a continuous video recording, or as a series of snapshots strung together?

According to Johns Hopkins scientists, who actually watched nerve cells firing in the brains of rats as they planned where to go next, it’s a series of snapshots — more like jumping across stepping stones than walking across a bridge.

“Our data from rats suggest that our memories are actually organized that way, with one network of neurons responsible for the snapshots and another responsible for the string that connects them,” says David Foster, Ph.D., an assistant professor of neuroscience at the Johns Hopkins University School of Medicine.

A summary of their experiments, published in the journal Science on July 10, sheds light on what memories are and how they form,and how the system could fail.

The 2014 Nobel Prize in Physiology or Medicine was awarded for the discovery of a positioning system in the brain. Grid cells, together with other cells in the entorhinal cortex of the brain that recognize the direction of the head and the border of the room, form networks with the place cells in the hippocampus. This circuitry constitutes a comprehensive positioning system in the brain that appears to have components similar to those of the rat brain. (Credit: Mattias Karlén/The Nobel Committee for Physiology or Medicine)

Foster and his team focused their experiments on a group of nerve cells in the hippocampus of the brain known — in animals and people — for creating a mental “map” of experiences, or memories. The cells are called place cells because they each develop a preferred place in an environment and mainly fire only when the animal is in that place.

In previous experiments, Foster’s group learned that when a rat wants to get from point A to point D, it maps out its route mentally before starting on its journey. They could “see” this happen by implanting many tiny wires in the brains of the rats so that they could monitor the activity of more than 200 place cells at a time. By doing so, they found that the place cells representing point A would fire first, followed by those for point B, then C and D.

Maps of gaps

Their latest work, says Foster, is essentially a higher resolution “map” of the same process, which revealed gaps in between points A, B, C and D, corresponding to actual “gaps”  between discrete “memories” in the rats’ brains.

“The trajectories that the rats reconstructed weren’t smooth,” says Foster. “We were able to see that neural activity ‘hovers’ in one place for about 20 milliseconds before ‘jumping’ to another place, where it hovers again before moving on to the next point.”

He says that what seems to be happening during the hovering phase is an individual memory is being strengthened or focused. “At first, you get a ‘blurry’ representation of point A because a bunch of place cells all around point A fire, but, as time passes, the activity becomes more focused on A,” he explains. Then the activity jumps to a “blurry” version of B, which then gets focused.

“We think that there is a whole network of cells dedicated to this process of fine-tuning and jumping,” says Foster. “Without it, memory retrieval would be even messier than it is.”

In the future, the group plans to see what happens when certain memories within a path go missing, hoping to learn more about what memories are and how we can preserve them in those suffering from Alzheimer’s disease and other cognitive disorders.


Abstract of Autoassociative dynamics in the generation of sequences of hippocampal place cells

Neuronal circuits produce self-sustaining sequences of activity patterns, but the precise mechanisms remain unknown. Here we provide evidence for autoassociative dynamics in sequence generation. During sharp-wave ripple (SWR) events, hippocampal neurons express sequenced reactivations, which we show are composed of discrete attractors. Each attractor corresponds to a single location, the representation of which sharpens over the course of several milliseconds, as the reactivation focuses at that location. Subsequently, the reactivation transitions rapidly to a spatially discontiguous location. This alternation between sharpening and transition occurs repeatedly within individual SWRs and is locked to the slow-gamma (25 to 50 hertz) rhythm. These findings support theoretical notions of neural network function and reveal a fundamental discretization in the retrieval of memory in the hippocampus, together with a function for gamma oscillations in the control of attractor dynamics.

Wireless device delivers drugs to brain and triggers neurons via remote control

Tiny, implantable devices are capable of delivering light or drugs to specific areas of the brain, potentially improving drug delivery to targeted regions of the brain and reducing side effects. Eventually, the devices may be used to treat pain, depression, epilepsy and other neurological disorders in people. (credit: Alex David Jerez Roman)

A team of researchers has developed a tiny “wireless optofluidic neural probe” the width of a human hair that can be implanted in the brain and triggered by remote control to deliver drugs and activate targeted populations of brain cells.

The technology, demonstrated for the first time in mice, may one day be used to treat pain, depression, epilepsy, and other neurological disorders in people by targeting therapies to specific brain circuits with fewer side effects, according to the researchers at Washington University School of Medicine in St. Louis and the University of Illinois at Urbana-Champaign.

Soft optofluidic neural probe during simultaneous drug delivery and photostimulation (from micro-ILED). Drugs would be delivered via the fluidic channel and activated with light as needed. (Insets) Comparison of such a device (top) and a conventional metal cannula (bottom). Scale bars, 1 mm. (credit: Jae-Woong Jeong et al./Cell)

The research builds on earlier work in optogenetics, a technology that makes individual brain cells sensitive to light and then activates those targeted populations of cells with flashes of light.

The study was published online today (July 16) in the journal Cell and will appear in the July 30 print issue.

Previous attempts to deliver drugs or other agents, such as enzymes or other compounds, to experimental animals have required the animals to be tethered to rigid pumps and tubes that restricted their movement and often caused them to experience stress.

Exploded-view schematic diagram that illustrates an array of inorganic light-emitting diodes mounted on top of a soft microfluidic system that includes four separate microfluidic channels, each connected to a set of fluid reservoirs that include copper membranes as hermetic seals, expandable composite materials as mechanical transducers, and microscale heating elements as actuators (credit: Jae-Woong Jeong et al./Cell)

The new wireless optofluidic neural probes were built with four chambers to carry drugs directly into the brain via microfluidic channels and microscale pumps, and the probes are soft like brain tissue.

New tool for mapping brain-circuit activity

A freely moving rat with head-mounted device for drug delivery and photostimulation via the optofluidic system. The device is remotely controlled via infrared technology, similar to that used in a TV remote. Scale bar, 1 cm. (credit: Jae-Woong Jeong et al./Cell)

By activating brain cells with drugs and with light, the scientists are getting an unprecedented look at the inner workings of the brain.

“This is the kind of revolutionary tool development that neuroscientists need to map out brain circuit activity,” said James Gnadt, PhD, program director at the National Institute of Neurological Disorders and Stroke at the National Institutes of Health (NIH).

“It’s very much in line with the goals of the NIH’s BRAIN Initiative, a program designed to accelerate the development and application of new technologies to shed light on the complex links between brain function and behavior.”

The new devices may ultimately also help people with neurological disorders and other problems, according to co-first author Jae-Woong Jeong, PhD, a former postdoctoral researcher at the University of Illinois and now assistant professor of electrical, computer and energy engineering at the University of Colorado, Boulder.

“The device can remain in the brain and function for a long time without causing inflammation or neural damage,” Jeong said.

The researchers also believe that similar, more flexible devices could have applications in areas of the body other than the brain, including peripheral organs.

Messing with mice minds 

As part of the study, the researchers, who clearly are having way too much fun, showed that by delivering a drug to one side of an animal’s brain, they could stimulate neurons involved in movement, which caused the mouse to move in a circle.

In other mice, shining a light directly onto brain cells expressing a light-sensitive protein prompted the release of dopamine, a neurotransmitter that rewarded the mice by making them feel good. The mice then returned to the same location in a maze to seek another reward. But the researchers were able to interfere with that light-activated pursuit by remotely controlling the release of a drug that blocks the action of dopamine on its receptors.

The researchers hope to incorporate a design much like a printer’s ink cartridge so that drugs can continue to be delivered to specific cells in the brain, or elsewhere in the body, for as long as required and needed to replace the entire device.


Abstract of Wireless Optofluidic Systems for Programmable In Vivo Pharmacology and Optogenetics

In vivo pharmacology and optogenetics hold tremendous promise for dissection of neural circuits, cellular signaling, and manipulating neurophysiological systems in awake, behaving animals. Existing neural interface technologies, such as metal cannulas connected to external drug supplies for pharmacological infusions and tethered fiber optics for optogenetics, are not ideal for minimally invasive, untethered studies on freely behaving animals. Here, we introduce wireless optofluidic neural probes that combine ultrathin, soft microfluidic drug delivery with cellular-scale inorganic light-emitting diode (m-ILED) arrays. These probes are orders of magnitude smaller than cannulas and allow wireless, programmed spatiotemporal control of fluid delivery and photostimulation. We demonstrate these devices in freely moving animals to modify gene expression, deliver peptide ligands, and provide concurrent photostimulation with antagonist drug delivery to manipulate mesoaccumbens rewardrelated behavior. The minimally invasive operation of these probes forecasts utility in other organ systems and species, with potential for broad application in biomedical science, engineering, and medicine.

Nanospheres safely deliver high chemotherapy doses to attack tumors

Cancer tumors secrete enzymes are triggered by peptide coatings (blue) to slice the coatings open, safely delivering an anti-cancer drug (red) (credit: Cassandra E. Callmann et al./Advanced Materials)

Scientists have engineered a drug delivery system that uses specially designed nanoparticles that release drugs in the presence of a specific enzymes — the very ones that enable cancers to metastasize.

“We can start with a small molecule and build that into a nanoscale carrier that can seek out a tumor and deliver a payload of drug,” said Cassandra Callmann, a graduate student in chemistry and biochemistry at the University of California, San Diego, and first author of the report published in the journal Advanced Materials July 14.

Trojan-horse strategy

The system takes advantage of a class of enzymes called matrix metalloproteinases (MMPs) that many cancers make in abundance. MMPs normally chew through through the body’s membranes, allowing cancer cells to escape to metastasize (colonize other regions of the body), often with deadly consequences.

Trojan-horse strategy: an anti-cancer drug (Paclitaxel) and a peptide self-assemble into nanoparticles. Released at the cancer location, the peptide shell triggers cancer-cell enzymes (MMP) to rip apart the nanoparticle shell, releasing the drug (credit: Cassandra E. Callmann/Advanced Materials)

So Callmann created tiny spheres packed with the anti-cancer drug paclitaxel (also known by the trade names Taxol and Onxal) and coated with a peptide shell. When MMPs sense the peptide, they go pitbull on it, tearing up that shell, and releasing the drug. The shell fragments form a ragged mesh that holds the drug molecules near the tumor.

The work, led by Nathan Gianneschi a professor of chemistry and biochemisty at UC San Diego, builds on his group’s earlier success using a similar strategy to mark tumors for both diagnosis and precise surgical removal.

16 times higher anti-cancer dose safely administered

To package the drug into the spheres, Callmann had to add chemical handles. As it turns out, a group of atoms essential to the drug molecule’s effectiveness, and also toxicity, made for a good attachment point. That means the drug was safely inactivated as it flowed through the circulatory system until it reached the tumor.

The protection allowed the researchers to safely give a dose 16 times higher than they could with the formulation now used in cancer clinics, in a test in mice with grafted in fibrosarcoma tumors.

In additional preliminary tests, Callmann and colleagues were able to halt the growth of the tumors for a least two weeks, using a single lower dose of the drug. In mice treated with the nanoparticles that were coated with peptides that are instead impervious to MMPs or given saline, the tumors grew to lethal sizes within that time.

Gianneschi says they will broaden their approach to create delivery systems for other diagnostic and therapeutic molecules. “This kind of platform is not specific to paclitaxel. We’ll test this in other models — with other classes of drug and in mice with a cancer that mimics metastatic breast cancer, for example.”

They’ll also continue to modify the shell, to provide even greater protection and avoid uptake by organs such as liver, spleen and kidneys, he said. “We want to open up this therapeutic window.”


Abstract of Therapeutic Enzyme-Responsive Nanoparticles for Targeted Delivery and Accumulation in Tumors

An enzyme-responsive, paclitaxel-loaded nanoparticle is described and assessed in vivo in a human fibrosarcoma murine xenograft. This work represents a proof-of-concept study demonstrating the utility of enzyme-responsive nanoscale drug carriers capable of targeted accumulation and retention in tumor tissue in response to overexpressed endogenous enzymes.

Continued destruction of Earth’s plant life places humankind in jeopardy, say researchers

Earth-space battery. The planet is a positive charge of stored chemical energy (cathode) in the form of fossil and nuclear fuels and biomass. As this energy is dissipated by humans, it eventually radiates as heat toward the chemical equilibrium of deep space (anode). The battery is rapidly discharging without replenishment. (credit: John R. Schramski et al./PNAS)

Unless humans slow the destruction of Earth’s declining supply of plant life, civilization like it is now may become completely unsustainable, according to a paper published recently by University of Georgia researchers in the Proceedings of the National Academy of Sciences.

“You can think of the Earth like a battery that has been charged very slowly over billions of years,” said the study’s lead author, John Schramski, an associate professor in UGA’s College of Engineering. “The sun’s energy is stored in plants and fossil fuels, but humans are draining energy much faster than it can be replenished.”

Number of years of phytomass food potentially available to feed the global human population (credit: John R. Schramski et al./PNAS)

Earth was once a barren landscape devoid of life, he explained, and it was only after billions of years that simple organisms evolved the ability to transform the sun’s light into energy. This eventually led to an explosion of plant and animal life that bathed the planet with lush forests and extraordinarily diverse ecosystems.

The study’s calculations are grounded in the fundamental principles of thermodynamics, a branch of physics concerned with the relationship between heat and mechanical energy. Chemical energy is stored in plants, or biomass, which is used for food and fuel, but which is also destroyed to make room for agriculture and expanding cities.

Scientists estimate that the Earth contained approximately 1,000 billion tons of carbon in living biomass 2,000 years ago. Since that time, humans have reduced that amount by almost half. It is estimated that just over 10 percent of that biomass was destroyed in just the last century.

“If we don’t reverse this trend, we’ll eventually reach a point where the biomass battery discharges to a level at which Earth can no longer sustain us,” Schramski said.

Major causes: deforestation, large-scale farming, population growth

Working with James H. Brown from the University of New Mexico, Schramski and UGA’s David Gattie, an associate professor in the College of Engineering, the research shows that the vast majority of losses come from deforestation, hastened by the advent of large-scale mechanized farming and the need to feed a rapidly growing population. As more biomass is destroyed, the planet has less stored energy, which it needs to maintain Earth’s complex food webs and biogeochemical balances.

NASA Earth Observatory biomass map of the U.S. by Robert Simmon, generated from the National Biomass and Carbon Dataset (NBCD) assembled by scientists at the Woods Hole Research Center

“As the planet becomes less hospitable and more people depend on fewer available energy options, their standard of living and very survival will become increasingly vulnerable to fluctuations, such as droughts, disease epidemics and social unrest,” Schramski said.

If human beings do not go extinct, and biomass drops below sustainable thresholds, the population will decline drastically, and people will be forced to return to life as hunter-gatherers or simple horticulturalists, according to the paper.

“I’m not an ardent environmentalist; my training and my scientific work are rooted in thermodynamics,” Schramski said. “These laws are absolute and incontrovertible; we have a limited amount of biomass energy available on the planet, and once it’s exhausted, there is absolutely nothing to replace it.”

Schramski and his collaborators are hopeful that recognition of the importance of biomass, elimination of its destruction and increased reliance on renewable energy will slow the steady march toward an uncertain future, but the measures required to stop that progression may have to be drastic.

The model does not take into account potential future breakthroughs in more efficient biomass use and alternate energy systems.


Abstract of Human domination of the biosphere: Rapid discharge of the earth-space battery foretells the future of humankind

Earth is a chemical battery where, over evolutionary time with a trickle-charge of photosynthesis using solar energy, billions of tons of living biomass were stored in forests and other ecosystems and in vast reserves of fossil fuels. In just the last few hundred years, humans extracted exploitable energy from these living and fossilized biomass fuels to build the modern industrial-technological-informational economy, to grow our population to more than 7 billion, and to transform the biogeochemical cycles and biodiversity of the earth. This rapid discharge of the earth’s store of organic energy fuels the human domination of the biosphere, including conversion of natural habitats to agricultural fields and the resulting loss of native species, emission of carbon dioxide and the resulting climate and sea level change, and use of supplemental nuclear, hydro, wind, and solar energy sources. The laws of thermodynamics governing the trickle-charge and rapid discharge of the earth’s battery are universal and absolute; the earth is only temporarily poised a quantifiable distance from the thermodynamic equilibrium of outer space. Although this distance from equilibrium is comprised of all energy types, most critical for humans is the store of living biomass. With the rapid depletion of this chemical energy, the earth is shifting back toward the inhospitable equilibrium of outer space with fundamental ramifications for the biosphere and humanity. Because there is no substitute or replacement energy for living biomass, the remaining distance from equilibrium that will be required to support human life is unknown.

Memory-loss case ‘like nothing we have ever seen before’

(credit: Newmarket Films)

Gerald Burgess, a University of Leicester lecturer in clinical psychology, has described treating an individual who suffered a “Memento/Before I Go to Sleep“-style anterograde amnesia memory loss after a treatment at a dentist — “like nothing we have ever seen before.”

Since the one-hour root-canal treatment, during which the a 38-year-old man from the UK was given a local anesthetic, the individual cannot remember anything beyond 90 minutes.

He is fully aware of his identity and his personality did not change, says Burgess, but every day the man thinks it is the day of his dental appointment. He has to manage his life through an electronic diary and access to prompts.

Burgess has now described the study, done a decade ago, in an open-access paper published in May in the journal Neurocase. He is also appealing for people who know of someone who might have suffered similar symptoms of memory loss, or medical or allied health professionals working with someone like this, to contact him to build up knowledge and evidence in this field of study.

Possible explanations

Burgess notes that “what we did know about from decades of research and hundreds of case studies, is that bilateral damage to the hippocampal and/or diencephalon structures causes profound amnesia … [but] we should perhaps not be so stuck in thinking that profound amnesia only occurs in the context of visible damage to the brain’s hippocampal and/or diencephalon structures.

“Those structures appear just to be needed for the initial holding or retention of information before engrams then proceed slowly through several other neuro-electrical and neuro-chemical events, before finally permanent memories are stored, and that something can occur at some later point in this process to vanquish the memory trace permanently.

“An acquired or manifest deficiency of protein synthesis, required for permanent re-structuring of synapses in the brain, seemed an intriguing speculation, and one we hope there might be further human research into. This speculation was sparked by two seemingly key coincidences of one, timing when this protein synthesis stage occurs coincides with the patient’s forgetting at 90 minutes or thereabouts, and two, both ‘episodic’ and ‘procedural’ memories appear to require successful protein synthesis to occur for long-term memory permanence, and the patient cannot retain any new either episodic or procedural memories — and this is unusual compared to traditional cases of amnesia.”

The work was done in collaboration with Bhanu Chadalavada Consultant Psychiatrist at Northamptonshire Healthcare Foundation NHS Trust.


Newmarket | Memento (2000) (HD Trailer)

A man creates a strange system to help him remember things; so he can hunt for the murderer of his wife without his short-term memory loss being an obstacle.


Scott Free | Before I Go To Sleep Official Trailer #1 (2014) – Nicole Kidman, Colin Firth Movie HD

A woman wakes up every day, remembering nothing as a result of a traumatic accident in her past. One day, new terrifying truths emerge that force her to question everyone around her.


Columbia Pictures | 50 First Dates Trailer

A man afraid of commitment thinks he’s finally found the girl of his dreams, until he discovers she has short-term memory loss and forgets him the very next day.


Abstract of Profound anterograde amnesia following routine anesthetic and dental procedure: a new classification of amnesia characterized by intermediate-to-late-stage consolidation failure?

Anterograde amnesia caused by bilateral hippocampal or diencephalon damage manifests in characteristic symptoms of preserved intellect and implicit learning, and short span of awareness with complete and rapid forgetting of episodic material. A new case, WO, 38-year-old male with anterograde amnesia, in the absence of structural brain changes or psychological explanation is presented, along with four comparison cases from the extant literature that share commonalities between them including preserved intellect, span of awareness greater than working memory, and complete forgetting within hours or days following successful learning, including notably for both explicit and implicit material. WO’s amnesia onset coincided with anesthetic injection and root canal procedure, with extended vasovagal-like incident. The commonalities between the five cases presented may suggest a shared biological mechanism involving the breakdown of intermediate-to-late-stage consolidation that does not depend on the structural integrity of the hippocampi. Speculation on the mechanism of consolidation breakdown and diagnostic implications are discussed.